Geneva, Oct. 27 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134544) titled 'Effects of Tirzepatide-Induced Weight Loss on Left Cardiac Structure and Function and Coronary Artery Lesions in Obese Patients: A Prospective Study' on Oct. 16.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Condition:
Obesity
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-04-22
Target Sample Size: Tirzepatide Intervention Group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=344659
Disclaimer: Curated by...